- Business Wire•yesterday
Agilent Technologies Inc. today introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the product.
- Business Wire•2 days ago
Agilent Technologies Inc., today announced that Samraat “Sam” Raha has been named senior vice president of strategy and corporate development, reporting to Agilent President and CEO Mike McMullen.
- Market Realist•6 days ago
The healthcare sector fell on Thursday amid the sell-off in healthcare-related stocks. The S&P 500 healthcare sector fell 0.9% on March 16.
A : Summary for Agilent Technologies, Inc. Comm - Yahoo Finance
Agilent Technologies, Inc. (A)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||52.65 - 53.47|
|52 Week Range||38.89 - 54.82|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||34.08|
|Dividend & Yield||0.53 (0.99%)|
|1y Target Est||N/A|